These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28648598)

  • 1. Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent l-lysine-containing domains.
    Gonzalez-Gronow M; Fiedler JL; Farias Gomez C; Wang F; Ray R; Ferrell PD; Pizzo SV
    Biochem Biophys Res Commun; 2017 Aug; 490(3):855-860. PubMed ID: 28648598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro.
    Gonzalez-Gronow M; Gomez CF; de Ridder GG; Ray R; Pizzo SV
    J Biol Chem; 2014 Sep; 289(36):25166-76. PubMed ID: 25059665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa.
    Grundy JE; Lavigne N; Hirama T; MacKenzie CR; Pryzdial EL
    Biochemistry; 2001 May; 40(21):6293-302. PubMed ID: 11371191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and activation of plasminogen on immobilized immunoglobulin G. Identification of the plasmin-derived Fab as the plasminogen-binding fragment.
    Harpel PC; Sullivan R; Chang TS
    J Biol Chem; 1989 Jan; 264(1):616-24. PubMed ID: 2521222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator.
    Arza B; Hoylaerts MF; Félez J; Collen D; Lijnen HR
    Eur J Biochem; 2000 Nov; 267(21):6378-84. PubMed ID: 11029580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A covalent molecular weight approximately 92,000 hybrid plasminogen activator derived from human plasmin fibrin-binding and tissue plasminogen activator catalytic domains.
    Robbins KC; Boreisha IG
    Biochemistry; 1987 Jul; 26(15):4661-7. PubMed ID: 3117104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin.
    Salonen EM; Saksela O; Vartio T; Vaheri A; Nielsen LS; Zeuthen J
    J Biol Chem; 1985 Oct; 260(22):12302-7. PubMed ID: 2413022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alpha.
    Arza B; Félez J; Fábregas P; Laroche Y; Collen D; Lijnen HR
    Thromb Haemost; 2000 Jul; 84(1):71-7. PubMed ID: 10928473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin.
    Parkkinen J; Rauvala H
    J Biol Chem; 1991 Sep; 266(25):16730-5. PubMed ID: 1909331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
    de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH
    Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
    Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
    Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
    Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
    Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin.
    Stack MS; Pizzo SV
    J Biol Chem; 1993 Sep; 268(25):18924-8. PubMed ID: 8360182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen.
    Stack MS; Pizzo SV
    Arch Biochem Biophys; 1994 Feb; 309(1):117-22. PubMed ID: 8117101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator.
    Kim PY; Tieu LD; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2012 Feb; 287(7):4652-61. PubMed ID: 22187433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
    Fischer B
    Biomed Biochim Acta; 1991; 50(1):47-54. PubMed ID: 1830477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen binds to plasmin-modulated factor Xa by Ca(2+) - and C-terminal lysine-dependent and -independent interactions.
    Grundy JE; Hancock MA; Meixner SC; MacKenzie RC; Koschinsky ML; Pryzdial EL
    Thromb Haemost; 2007 Jan; 97(1):38-44. PubMed ID: 17200769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.